Phreesia Story

PHR -- USA Stock

USD 29.68 0.28 0.93%

Macroaxis Story

It seems Phreesia may not recover as fast as we have hopped for as its price went down 5.8% today. The company's current daily volatility is 2.81 percent, with a beta of 1.15 and an alpha of 0.02 over DOW. As many of us are getting excited about latest market fluctuations it is important to sum up Phreesia based on its technical indicators. We will evaluate if Phreesia shares are reasonably priced going into October.

Published over a week ago

View all stories for Phreesia | View All Stories

Is Phreesia (NYSE:PHR) stock way too aggressive for baby boomers?

This firm runs under Healthcare sector within Health Information Services industry. Our advice module can be used to complement Phreesia recommendation provided by average analyst sentiment. It analyzes the firm's potential to grow using fundamental, technical, data market data available at the time.

Investing in Phreesia, just like investing in any other equity instrument, is characterized by a strong risk-return correlation. High risks mean high returns and low risk means lower expected returns. Risk management is the act of identifying and assessing the potential risk and developing strategies to minimize these risks and earn maximum possible profits while holding Phreesia along with other instruments in the same portfolio. Using conventional technical analysis and fundamental analysis to select individual securities into a portfolio complements risk management and adds value to overall investors' investing strategies.

How important is Phreesia's Liquidity

Phreesia financial leverage refers to using borrowed capital as a funding source to finance Phreesia ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Phreesia financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Phreesia's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for Phreesia, but it might be worth checking our own buy vs. sell analysis

Phreesia Correlation with Peers

Investors in Phreesia can reduce exposure to individual asset risk by holding a diversified portfolio of assets in addition to a long position in Phreesia. Diversification will allow for the same portfolio return with reduced risk. The correlation table of Phreesia and its peers is a two-dimensional matrix that shows the correlation coefficient between pairs of securities Phreesia is related in some way. The cells in the table are color-coded to highlight significantly positive and negative relationships. Each cell shows the correlation between one pair of equities and can be used to run pair trading strategies or create efficient portfolios with your current brokerage. Please check volatility of Phreesia for more details

What is driving Phreesia Investor Appetite?

We consider Phreesia very steady. Phreesia maintains Sharpe Ratio (i.e. Efficiency) of 0.0291, which implies the firm had 0.0291% of return per unit of risk over the last month. Our standpoint towards forecasting the volatility of a stock is to use all available market data together with stock specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Phreesia, which you can use to evaluate future volatility of the company. Please check Phreesia Coefficient Of Variation of 2111.11, risk adjusted performance of 0.0741, and Semi Deviation of 2.98 to confirm if the risk estimate we provide is consistent with the expected return of 0.0819%.

	MTHRF	CERN	PANHF	OMCL	PMCUF
MTHRF		0.47	0.07	0.24	0.04	MTHRF
CERN	0.47		0.2	0.41	-0.04	CERN
PANHF	0.07	0.2		-0.02	-0.61	PANHF
OMCL	0.24	0.41	-0.02		-0.07	OMCL
PMCUF	0.04	-0.04	-0.61	-0.07		PMCUF
	MTHRF	CERN	PANHF	OMCL	PMCUF

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Does Phreesia have anything more to report in September?

Latest Sortino Ratio is up to 0.01. Price may fall again. As of the 8th of September, Phreesia holds the Risk Adjusted Performance of 0.0741, semi deviation of 2.98, and Coefficient Of Variation of 2111.11. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Phreesia, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Phreesia, which can be compared to its competitors. Please check Phreesia information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Phreesia is priced some-what accurately, providing market reflects its current price of 31.0 per share. Given that Phreesia has jensen alpha of 0.0179, we recommend you to check out Phreesia's recent market performance to make sure the company can sustain itself at a future point.

Our Conclusion on Phreesia

While some firms within the health information services industry are still a little expensive, even after the recent corrections, Phreesia may offer a potential longer-term growth to retail investors. To summarize, as of the 8th of September 2020, our analysis shows that Phreesia almost mirrors the market. The enterprise is overvalued and projects very low probability of financial unrest for the next 2 years. Our latest 30 days advice on the enterprise is Cautious Hold.

About Contributor

Raphi Shpitalnik is a Junior Member of Macroaxs Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time base at the beginning of the pandemic and eventually acquired a real test for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Phreesia. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2020 Macroaxis LLC

Phreesia Story

USD 29.68 0.28 0.93%

How important is Phreesia's Liquidity

What do experts say?

Phreesia Correlation with Peers

What is driving Phreesia Investor Appetite?

Does Phreesia have anything more to report in September?

Our Conclusion on Phreesia

About Contributor

Would you like to provide feedback on the content of this article?

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY